Changes in the levels of IFN-γ, IL-17, and TNF-α, which are associated with both hyperglycemia and lung dysbiosis, are key players in the inflammatory circuits that control the progression of TB (Mori, Morrison and Blumenthal, 2021). This evidence concerns the gene IL17A and Hyperglycemia.